Publications
Cancer-Related Cognitive Impairment or "Chemobrain:" Emerging Assessments, Treatments, and Targets for Intervention
Chao, D,
Hale, A,
Henry, NL,
Kratz, AL,
Gabel, NM,
Current Physical Medicine and Rehabilitation Reports, 2021 Jul; Abstract 1418: Proanthocyanidins enhance chemotherapy-induced esophageal adenocarcinoma cell death
Zhang, Y,
Weh, K,
Howard, C,
Lagisetty, K,
McEwen, D,
Lin, J,
Reddy, RM,
Chang, A,
Beer, DG,
Howell, A,
Kresty, LA,
Cancer Research, 2021 Jul; DOI:10.1158/1538-7445.am2021-1418 Management of Cardiovascular Risk in Perimenopausal Women with Diabetes.
Diabetes Metab J, 2021 Jul; DOI:10.4093/dmj.2020.0262 Abstract 514: Specific anti-HER2 host immunity conferred by HER2-targeted antibody drug conjugate therapy and checkpoint blockade
Qin, Y,
Dobson, HE,
Comer, FI,
Chang, AE,
Wicha, MS,
Li, Q,
Cancer Research, 2021 Jul; DOI:10.1158/1538-7445.am2021-514 Application of an automatic segmentation method for evaluating cardiac structure doses received by breast radiotherapy patients
Jung, JW,
Mille, MM,
Ky, B,
Kenworthy, W,
Lee, C,
Yeom, YS,
Kwag, A,
Bosch, W,
MacDonald, S,
Cahlon, O,
Bekelman, JE,
Lee, C,
RadComp Consortium, Array,
Phys Imaging Radiat Oncol, 2021 Jul; DOI:10.1016/j.phro.2021.08.005 Abstract CT168: Changes in mast cell (MC) numbers and phenotype in patients (pts) with indolent systemic mastocytosis (ISM) treated with avapritinib
George, T,
Broesby-Olsen, S,
Wada, D,
Florell, S,
Hartman, K,
Siebenhaar, F,
Akin, C,
Newberry, K,
Shi, H,
Roche, M,
Maurer, M,
Elberink, HO,
Cancer Research, 2021 Jul; DOI:10.1158/1538-7445.am2021-ct168 A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)
Pienta, KJ,
Gorin, MA,
Rowe, SP,
Carroll, PR,
Pouliot, F,
Probst, S,
Saperstein, L,
Preston, MA,
Alva, AS,
Patnaik, A,
Durack, JC,
Stambler, N,
Lin, T,
Jensen, J,
Wong, V,
Siegel, BA,
Morris, MJ,
J Urol, 2021 Jul; DOI:10.1097/JU.0000000000001698 Utilization of Women's Preventive Health Services During the COVID-19 Pandemic
Becker, NV,
Moniz, MH,
Tipirneni, R,
Dalton, VK,
Ayanian, JZ,
JAMA Health Forum, 2021 Jul; DOI:10.1001/jamahealthforum.2021.1408 Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study
Tosoian, JJ,
Dunn, RL,
Niknafs, YS,
Saha, A,
Vince, RA,
St Sauver, JL,
Jacobson, DJ,
McGree, ME,
Siddiqui, J,
Groskopf, J,
Jacobsen, SJ,
Tomlins, SA,
Kunju, LP,
Morgan, TM,
Salami, SS,
Wei, JT,
Chinnaiyan, AM,
Sarma, AV,
Eur Urol Open Sci, 2021 Jul; DOI:10.1016/j.euros.2021.04.009 Abstract 2936: Ago2 induces Kras signaling and promotes tumor progression in mouse models of lung adenocarcinoma
Tien, JC,
Chugh, S,
Goodrum, AE,
Cheng, Y,
Wang, L,
Mannan, R,
Wang, X,
Dommeti, VL,
Zhang, Y,
Xu, A,
Su, F,
Cao, X,
Shankar, S,
Chinnaiyan, AM,
Cancer Research, 2021 Jul; DOI:10.1158/1538-7445.am2021-2936 The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms
Mather, RL,
Parolia, A,
Carson, SE,
Venalainen, E,
Roig-Carles, D,
Jaber, M,
Chu, S-C,
Alborelli, I,
Wu, R,
Lin, D,
Nabavi, N,
Jachetti, E,
Colombo, MP,
Xue, H,
Pucci, P,
Ci, X,
Hawkes, C,
Li, Y,
Pandha, H,
Ulitsky, I,
Marconett, C,
Quagliata, L,
Jiang, W,
Romero, I,
Wang, Y,
Crea, F,
Mol Oncol, 2021 Jul; DOI:10.1002/1878-0261.12954 Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis
Kamarajah, SK,
Bednar, F,
Cho, CS,
Nathan, H,
J Gastrointest Surg, 2021 Jul; DOI:10.1007/s11605-020-04879-x Factors Influencing Treatment of Veterans with Advanced Prostate Cancer.
Caram, MEV,
Burns, J,
Kumbier, K,
Sparks, JB,
Tsao, PA,
Chapman, CH,
Bauman, J,
Hollenbeck, BK,
Shahinian, VB,
Skolarus, TA,
Cancer, 2021 Jul; DOI:10.1002/cncr.33485 Adopting otitis media practice guidelines improved adherence within a large academic primary care network
Bradley, M,
Bacharouch, A,
Hart-Johnson, T,
Burrows, HL,
Blackwood, RA,
J Paediatr Child Health, 2021 Jul; DOI:10.1111/jpc.15389 Abstract 2162: Spatially resolved image-based transcriptomics using high-throughput single-molecule fluorescence in situ hybridization (HITSFISH)
Coleski, A,
Pitchiaya, S,
D'Silva, J,
Cieslik, M,
Chinnaiyan, A,
Cancer Research, 2021 Jul; DOI:10.1158/1538-7445.am2021-2162 Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Powles, T,
Csőszi, T,
Özgüroğlu, M,
Matsubara, N,
Géczi, L,
Cheng, SY-S,
Fradet, Y,
Oudard, S,
Vulsteke, C,
Morales Barrera, R,
Fléchon, A,
Gunduz, S,
Loriot, Y,
Rodriguez-Vida, A,
Mamtani, R,
Yu, EY,
Nam, K,
Imai, K,
Homet Moreno, B,
Alva, A,
KEYNOTE-361 Investigators, Array,
Lancet Oncol, 2021 Jul; DOI:10.1016/S1470-2045(21)00152-2 Abstract 1231: Identification of selective Brd4 degrader for cancer treatment
Hu, B,
Hu, J,
Xu, F,
Huang, L,
Wang, M,
Wang, S,
Cancer Research, 2021 Jul; DOI:10.1158/1538-7445.am2021-1231 Primary care physician perspectives on low-risk prostate cancer management: results of a national survey
Radhakrishnan, A,
Wallner, LP,
Skolarus, TA,
Shahinian, VB,
Abrahamse, PH,
Fetters, MD,
Hawley, ST,
Urol Pract, 2021 Jul; DOI:10.1097/UPJ.0000000000000231 Human Papilloma Virus Circulating Tumor DNA Assay Predicts Treatment Response in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Haring, CT,
Bhambhani, C,
Brummel, C,
Jewell, B,
Bellile, E,
Heft Neal, ME,
Sandford, E,
Spengler, RM,
Bhangale, A,
Spector, ME,
McHugh, J,
Prince, ME,
Mierzwa, M,
Worden, FP,
Tewari, M,
Swiecicki, PL,
Brenner, JC,
Oncotarget, 2021 Jun; DOI:10.18632/oncotarget.27992 What can heart failure trialists learn from oncology trialists?
Zannad, F,
Cotter, G,
Alonso Garcia, A,
George, S,
Davison, B,
Figtree, G,
Prasad, K,
Rockhold, F,
Schilsky, RL,
Stockbridge, N,
Pitt, B,
Butler, J,
Eur Heart J, 2021 Jun; DOI:10.1093/eurheartj/ehab236 Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer
Kwon, DH,
Chou, J,
Yip, SM,
Reimers, MA,
Zhang, L,
Wright, F,
Dhawan, MS,
Borno, HT,
Desai, A,
Aggarwal, RR,
Wyatt, AW,
Small, EJ,
Alva, AS,
Chi, KN,
Feng, FY,
Koshkin, VS,
Cancer, 2021 Jun; DOI:10.1002/cncr.33487 Altering the microbiome inhibits tumorigenesis in a mouse model of oviductal high-grade serous carcinoma
Chen, L,
Zhai, Y,
Wang, Y,
Fearon, ER,
Núñez, G,
Inohara, N,
Cho, KR,
Cancer Res, 2021 Jun; DOI:10.1158/0008-5472.CAN-21-0106 The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics. J Clin Invest.
Giblin, W,
Bringman-Rodenbarger, L,
Guo, AH,
Kumar, S,
Monovich, AC,
Mostafa, AM,
Skinner, ME,
Azar, M,
Mady, AS,
Chung, CH,
Kadambi, N,
Melong, K-A,
Lee, H-J,
Zhang, L,
Sajjakulnukit, P,
Trefely, S,
Varner, EL,
Iyer, S,
Wang, M,
Wilmott, JS,
Soyer, HP,
Sturm, RA,
Pritchard, AL,
Andea, AA,
Scolyer, RA,
Stark, MS,
Scott, DA,
Fullen, DR,
Bosenberg, MW,
Chandrasekaran, S,
Nikolovska-Coleska, Z,
Verhaegen, ME,
Snyder, NW,
Rivera, MN,
Osterman, AL,
Lyssiotis, CA,
Lombard, DB,
J Clin Invest, 2021 Jun; DOI:10.1172/JCI138926 Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
Zhang, Y,
Narayanan, SP,
Mannan, R,
Raskind, G,
Wang, X,
Vats, P,
Su, F,
Hosseini, N,
Cao, X,
Kumar-Sinha, C,
Ellison, SJ,
Giordano, TJ,
Morgan, TM,
Pitchiaya, S,
Alva, A,
Mehra, R,
Cieslik, M,
Dhanasekaran, SM,
Chinnaiyan, AM,
Proc Natl Acad Sci U S A, 2021 Jun; DOI:10.1073/pnas.2103240118 SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Zhou, H,
Bai, L,
Xu, R,
McEachern, D,
Chinnaswamy, K,
Li, R,
Wen, B,
Wang, M,
Yang, C-Y,
Meagher, JL,
Sun, D,
Stuckey, JA,
Wang, S,
ACS Med Chem Lett, 2021 Jun; DOI:10.1021/acsmedchemlett.1c00155 